Multiple PTI supporters across social media platforms were sharing a dim clip of party founder Imran Khan since February 24, 2026, claiming that it was from his latest visit to the Pakistan Institute of Medical Sciences (Pims) for a second eye injection. However, the video is old from February 20, 2023, when he appeared before the Lahore High Court (LHC) for interim protective bail in a case. The iVerify Pakistan team investigated this content and determined that it is false. Imran was brought to Pims for a follow-up eye treatment on Feb 24. According to a doctor, he was brought to the hospital for a second dose of anti-VEGF intravitreal injection. Imran’s eye ailment — right central retinal vein occlusion (CRVO) — came to light in late January 2026. His first medical procedure, which was carried out on January 24, was confirmed by the government five days later. Since then, the government and the opposition have also been engaged in a blame game, with the latter accusing the former of a lack of transparency ...
PTI founder Imran Khan — who is suffering from an eye ailment leading to loss of vision in his right eye — was examined by a team of doctors at Rawalpindi’s Adiala jail on Sunday. The party had rejected the inspection conducted in the absence of his family and personal physicians, terming it “malicious”. On Monday, the law minister allayed concerns Imran’s vision loss, saying that there was “nothing as such to worry about”. Meanwhile, the doctors who examined the former premier in jail released a two-page report on Monday. According to the report, a copy of which is available with Dawn, a medical board comprising the following eye specialists examined Imran on February 15; Dr Prof Nadeem Qureshi, the head of the vitreoretinal department at the Al-Shifa Trust Eye Hospital in Rawalpindi, and Dr Prof Dr M Arif, the head of the opthalmology department at the Pakistan Institute of Medical Sciences (Pims) in Islamabad. The report stated that unaided, Imran’s right eye had 6/24 partial vision and 6/9 in the left. It...